Process for the preparation of enantiomerically enriched esters and alcohols
View Patent ↗Method for the preparation of an enantiomerically enriched ester, in which a mixture of the enantiomers of the corresponding secondary alcohol is subjected, in the presence of an acyl donor, to an enantioselective conversion in the presence of a racemisation catalyst upon which the ester is formed and an acyl donor residue is obtained, and in which the acyl donor residue is irreversibly removed from the phase in which the enantioselective conversion takes place. Preferably the enantioselective conversion is carried out enzymatically and a transfer hydrogenation catalyst is used as racemisation catalyst. The secondary alcohol can be formed in situ from the corresponding ketone, in the presence of a hydrogen donor. It is also possible to use a mixture of the secondary alcohol and the corresponding ketone as substrate. Preferably the acyl donor is chosen so that the acyl donor residue is converted in situ into another compound and/or the acyl donor residue is removed via distillation under reduced pressure. The enantiomerically enriched esters obtained can subsequently be converted into the corresponding enantiomerically enriched alcohols, which are desirable intermediate products in the preparation of liquid crystals, agro chemicals or pharmaceuticals.
1. Process for the preparation of an enantiomerically enriched ester, which comprises subjecting a mixture of enantiomers of the corresponding secondary alcohol and an acyl donor, to an enantioselective conversion in the presence of a racemisation catalyst to form the corresponding ester and a residue of the acyl donor, and irreversibly removing the residue from the phase in which the enantioselective conversion takes place.
2. Process according to claim 1 in which the concentrations of secondary alcohol and acyl donor are higher than 1M.
3. Process according to claim 2 wherein said concentrations are higher than 2M.
4. Process according to claim 1 which is performed in the absence of solvent.
5. Process according to claim 1 , wherein the enantioselective conversion is an enzymatic conversion.
6. Process according to claim 1 , wherein the racemisation catalyst is a transfer hydrogenation catalyst.
7. Process according to claim 1 , wherein the racemisation catalyst comprises Ru or Ir.
8. Process according to claim 7 , wherein the racemisation catalyst contains an amino acid amide of the formula (1)
wherein
R 1 and R 4 each independently represent H, an alkyl or a phenyl group;
R 2 and R 3 each independently represent H or an alkyl group; or
R 1 and R 2 form a ring together with the N and C atoms to which they are bound.
9. Process according to claim 1 , wherein the enantioselective conversion is performed in the presence of a ketone.
10. Process according to claim 1 , wherein the secondary alcohol is generated in situ from the corresponding ketone in the presence of a hydrogen donor.
11. Process according to claim 10 , wherein said generating is in the presence of a reducing agent.
12. Process according to claim 1 , wherein residue of the acyl donor is converted in situ into another compound.
13. Process according to claim 1 , in which the residue of the acyl donor is removed via distillation under reduced pressure.
14. Process according to claim 13 , in which the acyl donor is a carboxylic acid ester of an alcohol (1-7C).
15. Process according to claim 14 wherein the acyl donor is the ester of an alcohol (1-4C) and a carboxylic acid (4-20C).
16. Process according to claim 1 , which further comprises converting the enantiomerically enriched ester obtained into the corresponding enantiomerically enriched alcohol.
17. Process according to claim 16 , in which the converting is in the presence of an enantioselective enzyme.
18. Process according to claim 1 , which further comprises converting the enantiomerically enriched ester into a liquid crystal, an agrochemical or a pharmaceutical.
19. Process according to claim 16 , which further comprises converting the enantiomerically enriched alcohol into a liquid crystal, an agrochemical or a pharmaceutical.